Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) just unveiled an update.
Shanghai MicroPort MedBot (Group) Co., Ltd. has established a Remuneration and Appraisal Committee under its board of directors to enhance corporate governance. This committee is responsible for formulating appraisal standards and reviewing remuneration policies for directors, supervisors, and senior management, which is expected to optimize the company’s management system and accountability.
The most recent analyst rating on (HK:2252) stock is a Sell with a HK$20.00 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. operates in the medical technology industry and focuses on developing robotic-assisted surgical systems. The company is incorporated in the People’s Republic of China and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 5,962,532
Technical Sentiment Signal: Buy
Current Market Cap: HK$22.42B
For a thorough assessment of 2252 stock, go to TipRanks’ Stock Analysis page.